CB1 Capital - Are they still on board?2 years ago but still relevant, since we are now in the transitional year. Interview on Midas Letter with CB1's Todd Harrison, quote: " James West: Interesting. So are there any names you can with us of up-and-coming companies that youre particularly excited about? Todd Harrison: Well, on the biotech side, GW, I talked about Corbus, were big fans of. I mean, theres a few others; on a biosythentic side, theres a company called InMed Pharmaceuticals, which is early, right, pre-clinical, but its a biosythentic, and we think the trend is really going to move towards biosythentics, away from the more traditional farming side. So whenever we look at investments, with the exception of Village Farms, which we think is a unique situation given their US and Mexican optionality, we really try to steer clear of the pure cultivators, because we think the farming side is probably the least sexy side of the equation, right?"